EUVIMEDEUVIMED entdecken
Crossref

Associations of Cardiovascular-Kidney-Metabolic Syndrome (CKM) Stages with All-Cause Mortality and Longitudinal Transitions of CKM Stages in a Population-Based Cohort

Haozhe Ding, Kuiying Gu, Sumei Yuan, Qi Huang, Chenxinan Ma, Qian Di, Jiming Zhu, Yining Yang, Gang Sun, Zhongxiao Wan

Heart, Lung and Circulation · 2026-07 · 35 (7) · 947-957

DOI: 10.1016/j.hlc.2026.01.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Heart, Lung and Circulation, 2026-07. Verfasst von Haozhe Ding und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, MOE Key Laboratory of Geriatric Dise…. Hauptthemen laut MEDLINE: Metabolic Syndrome, Cardio-Renal Syndrome, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Tsinghua University, Priority Academic Program Development of Jiangsu Higher Education Institutions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cardiovascular-kidney-metabolic (CKM) syndrome is a major global public health challenge. In Northwestern China, which has unique socio-economic and demographic characteristics and arid climate, its prevalence, stage transition dynamics, and mortality associations remain unexplored. METHOD: We included 9,116,728 adults aged ≥18 years who underwent annual health check-ups between 2019 and 2023 in Northwestern China. Cardiovascular-kidney-metabolic (CKM) stages were defined according to the American Heart Association criteria. Mortality information was obtained from local death registrations. Multivariable-adjusted Cox regression models estimated hazard ratios (HRs) of mortality risk associated with CKM stages. The probabilities of CKM stage transition and progression to death were estimated using a multistate Markov model. RESULTS: During a median follow-up of 3.78 years, the average prevalence of stages 1-4 CKM was 88.1%. Stage 2 CKM syndrome was the most prevalent (53.9%), and stage 4 showed a significant upward trend (annual percentage change, 23.03%; 95% confidence interval [CI] 22.63-23.43). Patients with stages 2-4 CKM were at increased risk of all-cause mortality, with HRs (95% CIs) of 1.15 (1.13-1.17), 1.43 (1.40-1.46), and 2.93 (2.88-2.99) for stages 2, 3, and 4, respectively, compared with stage 0. Stage 4 had the highest 5-, 10-, and 20-year cumulative death probabilities (12.3%, 16.0%, and 24.2%, respectively), whereas 68.7%-80.6% of individuals with non-advanced stages of CKM remained in or transitioned between stages 1-3 over 20 years. CONCLUSIONS: Adults in Northwestern China are facing a substantial CKM burden. CKM stage 4 has emerged as a critical risk end point, with its prevalence and associated mortality accelerating, while stages 0-3 CKM are highly reversible. Findings from this study highlight the need for early screening, dynamic monitoring of CKM stages, and optimisation of interventions focussing on preventing progression to stage 4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeCardio-Renal SyndromeCardiovascular DiseasesHumansFemaleChinaMiddle AgedMaleFollow-Up StudiesSurvival RateAdultRisk FactorsPrevalenceCause of DeathDisease Progression

Stichwörter der Autor:innen

Cardiovascular-kidney-metabolic syndromeMarkov modelMortalityStage transitions

Autor:innen und Institutionen

  • School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, MOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Medical College of Soochow University, Soo…
  • Vanke School of Public Health, Tsinghua University, Beijing, China.
  • Programme in Health Services and Systems Research, Duke-NUS Medical School, Singapore.
  • Department of Cardiology, People's Hospital of Xinjiang Uygur Autonomous Region, Ürümqi, China; Xinjiang Key Laboratory of Cardiovascular Homeostasis and Regeneration Research, Ürümqi, China.
  • Department of Breast and Thyroid Surgery, People's Hospital of Xinjiang Uygur Autonomous Region, Ürümqi, China; Key Laboratory of Oncology of Xinjiang Uygur Autonomous Region, Ürümqi, China. Electronic address: sungang@…

Förderung

  • National Natural Science Foundation of China
  • Tsinghua University
  • Priority Academic Program Development of Jiangsu Higher Education Institutions

Zitieren

APA

Ding, H., Gu, K., Yuan, S., Huang, Q., Ma, C., Di, Q., Zhu, J., Yang, Y., Sun, G., & Wan, Z. (2026). Associations of Cardiovascular-Kidney-Metabolic Syndrome (CKM) Stages with All-Cause Mortality and Longitudinal Transitions of CKM Stages in a Population-Based Cohort. Heart, Lung and Circulation, 35(7), 947-957. https://doi.org/10.1016/j.hlc.2026.01.010

Vancouver

Ding H, Gu K, Yuan S, Huang Q, Ma C, Di Q, et al. Associations of Cardiovascular-Kidney-Metabolic Syndrome (CKM) Stages with All-Cause Mortality and Longitudinal Transitions of CKM Stages in a Population-Based Cohort. Heart, Lung and Circulation. 2026;35(7):947-957. doi:10.1016/j.hlc.2026.01.010

BibTeX
@article{Ding2026,
  author = {Ding, Haozhe and Gu, Kuiying and Yuan, Sumei and Huang, Qi and Ma, Chenxinan and Di, Qian and Zhu, Jiming and Yang, Yining and Sun, Gang and Wan, Zhongxiao},
  title = {Associations of Cardiovascular-Kidney-Metabolic Syndrome (CKM) Stages with All-Cause Mortality and Longitudinal Transitions of CKM Stages in a Population-Based Cohort},
  journal = {Heart, Lung and Circulation},
  year = {2026},
  volume = {35},
  number = {7},
  pages = {947--957},
  doi = {10.1016/j.hlc.2026.01.010}
}
Kostenlos starten →